Rhumbline Advisers Sells 575 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Rhumbline Advisers decreased its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 1.0% during the 4th quarter, HoldingsChannel reports. The fund owned 59,445 shares of the biotechnology company’s stock after selling 575 shares during the period. Rhumbline Advisers’ holdings in Ligand Pharmaceuticals were worth $6,370,000 as of its most recent filing with the […]
Rhumbline Advisers decreased its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 1.0% during the 4th quarter, HoldingsChannel reports. The fund owned 59,445 shares of the biotechnology company’s stock after selling 575 shares during the period. Rhumbline Advisers’ holdings in Ligand Pharmaceuticals were worth $6,370,000 as of its most recent filing with the […]
